Differential outcomes of residual disease in surgically-resected non-small cell lung cancer and the importance of guideline-concordant adjuvant therapy.
Lieu DK, Ding L, David EA, Wightman SC, Atay SM, McFadden PM, Kim AW. Differential outcomes of residual disease in surgically-resected non-small cell lung cancer and the importance of guideline-concordant adjuvant therapy. J Thorac Dis. 2021 May; 13(5):2896-2909.